SigmaGraft Biomaterials
  • BONE
    SUBSTITUTE
    • InterOss®
    • InterOss® Syringe
    • InterOss® Collagen
      • Block Type
      • Plug Type
    • BoneSigma™ BCP
    • BoneSigma™ TCP
  • RESORBABLE
    MEMBRANE
  • SYNTHETIC
    CERAMIC
  • About Us
  • Contact
  • Careers
  • English
    • Spanish
    • Chinese (Simplified)
    • Korean
    • German
    • French
    • Russian
  • BONE
    SUBSTITUTE
    • InterOss®
    • InterOss® Syringe
    • InterOss® Collagen
      • Block Type
      • Plug Type
    • BoneSigma™ BCP
    • BoneSigma™ TCP
  • RESORBABLE
    MEMBRANE
  • SYNTHETIC
    CERAMIC
  • About Us
  • Contact
  • Careers
  • English
    • Spanish
    • Chinese (Simplified)
    • Korean
    • German
    • French
    • Russian

BCP Clinical Study 5

Patient presented with poor #27 and the tooth was extracted
View Larger

Patient presented with poor #27 and the tooth was extracted

After 2 months healing time
View Larger

After 2 months healing time

Sinus graft with BoneSigma™ BCP and InterOss® using the double window antrostomy approach
View Larger

Sinus graft with BoneSigma™ BCP and InterOss® using the double window antrostomy approach

BoneSigma™ BCP  was used for the anterior and InterOss®for the posterior
View Larger

BoneSigma™ BCP was used for the anterior and InterOss®for the posterior

View Larger

Postoperative x-ray
View Larger

Postoperative x-ray

View Larger

After 4 months healing, implants were placed
View Larger

After 4 months healing, implants were placed

Postoperative X-ray (4 months healing)
View Larger

Postoperative X-ray (4 months healing)

After an additional 3 months of healing, implants were loaded
View Larger

After an additional 3 months of healing, implants were loaded

Final Restoration
View Larger

Final Restoration

Company Headquarters

575 Sally Place, Fullerton, CA 92831, USA
P : 888-499-0114 (toll free), +1 714-525-0114
E : info@sigmagraft.com

Products

  • Bone Substitute
  • Resorbable Membrane
  • Synthetic Bioceramic

Follow Us

  • facebook
  • instagram
  • twitter
  • youtube
  • linkedin

Accessibility Statement